Literature DB >> 3469047

Stability of the maxilla after Le Fort III advancement in craniosynostosis syndromes.

D K Ousterhout, K Vargervik, S Clark.   

Abstract

The purpose of this study was to assess long-term position of the maxilla after surgical Le Fort III advancement of midfacial structures in patients with craniosynostosis syndromes. Data from preoperative, short and long-term postoperative lateral head films on 21 consecutive patients with Crouzon's syndrome, Pfeiffer's syndrome, or Apert's syndrome were analyzed. A method of evaluating the position of the postoperative maxilla on lateral head films is described. On average, the position of the maxilla did not change significantly in the postoperative periods studied, although some individual variation was demonstrated. Postoperative management, utilizing a registration bite splint after the intermaxillary fixation has been removed, similar to our treatment following bone grafting procedures in patients with hemifacial microsomia, is described.

Entities:  

Mesh:

Year:  1986        PMID: 3469047

Source DB:  PubMed          Journal:  Cleft Palate J        ISSN: 0009-8701


  3 in total

1.  Guideline for Care of Patients With the Diagnoses of Craniosynostosis: Working Group on Craniosynostosis.

Authors:  Irene M J Mathijssen
Journal:  J Craniofac Surg       Date:  2015-09       Impact factor: 1.046

2.  BaS analysis: a new cephalometric study for craniofacial malformations.

Authors:  Sandro Pelo; Laura Cacucci; Roberto Boniello; Alessandro Moro; Roberto Deli; Cristina Grippaudo; Concezio Di Rocco; Gianpiero Tamburrini; Luca Massimi; Massimo Caldarelli; Giulio Gasparini
Journal:  Childs Nerv Syst       Date:  2009-02-27       Impact factor: 1.475

3.  Evaluation of cephalometric points in midface bone lengthening with the use of a rigid external device in syndromic craniosynostosis patients.

Authors:  Daniel Santos Corrêa Lima; Nivaldo Alonso; Paulo Roberto Pelúcio Câmara; Dov Charles Goldenberg
Journal:  Braz J Otorhinolaryngol       Date:  2009 May-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.